Christina Lampe
Overview
Explore the profile of Christina Lampe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
805
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiesinger A, Bigger B, Giugliani R, Lampe C, Scarpa M, Moser T, et al.
J Inherit Metab Dis
. 2024 Nov;
48(1):e12816.
PMID: 39572375
Mucopolysaccharidosis (MPS) encompasses a group of genetic lysosomal storage disorders, linked to reduced life expectancy and a significant lack of effective treatment options. Immunomodulatory drugs could have the potential to...
2.
Kampmann C, Lampe C, Wiethoff C, Arash-Kaps L, Mengel E, Reinke J, et al.
J Inherit Metab Dis
. 2024 Oct;
48(1):e12808.
PMID: 39440439
Mucopolysaccharidosis II (MPS II, Hunter syndrome) is a rare, X-linked lysosomal storage disease caused by reduced activity of iduronate-2-sulfatase (I2S), with subsequent cellular accumulation of the glycosaminoglycans (GAGs), heparan sulfate,...
3.
Guffon N, Burton B, Ficicioglu C, Magner M, Gil-Campos M, Lopez-Rodriguez M, et al.
Mol Genet Metab
. 2024 Jul;
142(4):108519.
PMID: 39024860
Introduction: Current literature lacks consensus on initial assessments and routine follow-up care of patients with alpha-mannosidosis (AM). A Delphi panel was conducted to generate and validate recommendations on best practices...
4.
Wiesinger A, Bigger B, Giugliani R, Lampe C, Scarpa M, Moser T, et al.
Pharmaceutics
. 2023 Nov;
15(11).
PMID: 38004626
The journal retracts the article, An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis [...].
5.
Ortmann S, Marx J, Lampe C, Handrick V, Ehnert T, Zinecker S, et al.
PLoS Pathog
. 2023 Aug;
19(8):e1011263.
PMID: 37578981
Pathogenic Xanthomonas bacteria cause disease on more than 400 plant species. These Gram-negative bacteria utilize the type III secretion system to inject type III effector proteins (T3Es) directly into the...
6.
Wiesinger A, Bigger B, Giugliani R, Lampe C, Scarpa M, Moser T, et al.
Pharmaceutics
. 2023 May;
15(5).
PMID: 37242808
Mucopolysaccharidosis (MPS) is a group of rare metabolic diseases associated with reduced life expectancy and a substantial unmet medical need. Immunomodulatory drugs could be a relevant treatment approach for MPS...
7.
Niederau C, Regenbogen C, Fruehauf H, Merkel M, Ziagaki A, Mengel E, et al.
Z Gastroenterol
. 2023 Apr;
61(4):375-380.
PMID: 37040780
Background: Continuation of standard management of Gaucher disease (GD) has been challenging during the COVID-19 pandemic, resulting in infrequent/missed infusions and follow-up appointments. Little data are available on the consequences...
8.
Wiesinger A, Bigger B, Giugliani R, Scarpa M, Moser T, Lampe C, et al.
Front Pharmacol
. 2022 Jun;
13:863667.
PMID: 35645812
Mucopolysaccharidoses (MPS) are a group of lysosomal storage diseases (LSDs), characterized by the accumulation of glycosaminoglycans (GAGs). GAG storage-induced inflammatory processes are a driver of cytopathology in MPS and pharmacological...
9.
Magner M, Almassy Z, Gucev Z, Kiec-Wilk B, Plaiasu V, Tylki-Szymanska A, et al.
Orphanet J Rare Dis
. 2022 May;
17(1):190.
PMID: 35538504
Background: Mucopolysaccharidosis IVA (MPS IVA), or Morquio A syndrome, is a rare inherited metabolic disorder caused by deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfatase. A progressive systemic skeletal chondrodysplasia, leading to...
10.
Tylki-Szymanska A, Almassy Z, Christophidou-Anastasiadou V, Avdjieva-Tzavella D, Barisic I, Cerkauskiene R, et al.
Orphanet J Rare Dis
. 2022 Mar;
17(1):136.
PMID: 35331284
Background: Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by defects in genes coding for different lysosomal enzymes which degrade glycosaminoglycans. Impaired lysosomal degradation causes cell dysfunction leading...